(3.235.101.50)
Users online: 2698    [ij] [ij] [ij] 
Email id
 

Asian Journal of Pharmaceutical Analysis
Year : 2019, Volume : 9, Issue : 4
First page : ( 219) Last page : ( 223)
Print ISSN : 2231-5667. Online ISSN : 2231-5675.
Article DOI : 10.5958/2231-5675.2019.00037.1

Development and Validation of Difference Spectrophotometric Method for Quantitative Estimation of Gemcitabine Hydrochloride Injection

Kumar P Ravi*, Spandana P, Shareef Amani, Sahithi K, Babu N Raghavendra

G. Pulla Reddy College of Pharmacy, Mehdipatnam, Hyderabad, Telangana

*Corresponding Author E-mail: pravikumar@gprcp.ac.in

Online published on 31 December, 2019.

Abstract

Gemcitabine hydrochloride is used as an anti-cancer drug. The aim of the present study is to develop difference spectrophotometric method for the estimation of gemcitabine in bulk and lyophilized powder for injection. Difference spectrophotometric method has been developed for quantification of gemcitabine in injection formulation. The method was developed by measuring the difference spectral characteristics of the drug in 0.1N HCL and 0.1N NaOH at absorption maximum of 236nm. Beers law was obeyed in the concentration range of 525μg/ml. The LOD and LOQ were found to be 0.43 and 1.30μg/ml respectively with coefficient of correlation 0.999. The proposed method has been validated for linearity, accuracy and precision as per ICH guidelines and applied for quantitative analysis of gemcitabine hydrochloride injection.

Top

Keywords

Gemcitabine hydrochloride, Difference spectrophotometric method, Beer's law.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
447,497,155 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.